Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Memorial Sloan-Kettering Cancer Center
Welcome,
Profile
Billing
Logout
24 Products
12 Diseases
24 Products
30 Trials
1033 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Zeltherva
(galinpepimut-S) / SELLAS Life Sciences
Omblastys
(131I-omburtamab) / Y-mAbs Therap
vadacabtagene leraleucel
(JCAR015) / BMS
2141-V11
/ Memorial Sloan-Kettering Cancer Center, Rockefeller University
zelavespib intravenous
(PU-H71 IV) / Samus Therap
MCARH109
/ Eureka Therap, BMS, Memorial Sloan-Kettering Cancer Center, Sanofi
ATA2271
/ Memorial Sloan-Kettering Cancer Center
FT819
/ Fate Therap, Memorial Sloan-Kettering Cancer Center
SER-155
/ Memorial Sloan-Kettering Cancer Center, Seres Therap
nivatrotamab
(GD2xCD3) / Y-mAbs Therap
GD2-GD3 Vaccine
/ Y-mAbs Therap
JCAR020
/ BMS, Eureka Therap
MCARH125
/ Memorial Sloan-Kettering Cancer Center
MCARH171
/ BMS, Eureka Therap, Memorial Sloan-Kettering Cancer Center
Thalagen
(autologous CD34+ cells transduced with TNS9.3.55) / San Rocco Therap, Memorial Sloan-Kettering Cancer Center
Xenogeneic vaccine
/ Memorial Sloan-Kettering Cancer Center, Ichor Medical Systems
engineered autologous T cells
/ Memorial Sloan-Kettering Cancer Center
iCasp9M28z T cell infusion
/ Memorial Sloan-Kettering Cancer Center, Bellicum
iso-fludelone
(KOS-1803) / Memorial Sloan-Kettering Cancer Center
mouse TYRP2 DNA
/ Memorial Sloan-Kettering Cancer Center
phenformin
/ Memorial Sloan-Kettering Cancer Center